The safety of topical beta-blockers in glaucoma treatment.
Gale
A E
AE
D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D015784:Betaxolol / Q000627:therapeutic use; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans
D000319:Adrenergic beta-Antagonists; D015784:Betaxolol